Skip to main content

CPR

Most Viewed

CPR News

.
.
.
. .
.
http://omhthe.com/Gonzalis-brother-of-Petrini-from-Aranaú?Kavaneysi=118

Cheers went up last August when the U.S. Food and Drug Administration approved the world’s first CAR-T cancer cell treatment, Novartis’ Kymriah, and again in October when it approved Gilead’s CAR-T treatment for non-Hodgkin's lymphoma. In CAR-T therapy, the immune system’s killer T cells are modified to target specific tumors, giving physicians a powerful new tool to treat cancer.

But when it comes to the long-term development of this revolutionary treatment, China is poised to leapfrog the U.S. Consider these statistics from the Cell Trials Data Project:

.
.

In April, hospital leaders told the Times that surgical needles had been left behind in two patients since 2016. Dr. Jonathan Ellen, the CEO, also said the mortality rate among heart surgery patients had gone up in 2017, but declined to release the exact figure. The hospital’s latest four-year average is roughly the national average.

.
.